17th Annual BioPartnering Europe™ and BioPartnering China™ Presents Innovative and Informative Program, Addressing Latest Trends Affecting the Biotech Industry Today
LONDON-(Business Wire)-September 24, 2009 - Technology Vision Group (TVG) is pleased to announce details of the program for the 17th Annual BioPartnering Europe (BPE) and BioPartnering China (BPC) conference in London from 11-14 October 2009, providing four days of networking in one location. BPE’s continued popularity is due to the innovative and informative program which annually addresses the latest trends affecting the biotech industry today. This year, the conference is not only offering an exciting and interesting range of leadership sessions, workshops and presentations at BPE but also the chance for delegates to further their knowledge of the exciting Chinese market at an extra one-day event, BPC.
Highlights of this year’s program include five BioPartnering Leadership Sessions, where senior executives and industry leaders will address cutting-edge themes of interest to the life science community in a number of panel discussions. Four industry workshops by leading service providers will also offer one-hour workshops on unique topics in an interactive environment. Over 100 presenting companies will showcase their products and partnering goals, and nine leading pharmaceutical companies will give featured presentations.
BioPartnering Leadership Sessions Address Cutting-Edge Themes
This year’s conference offers some highly topical leadership sessions featuring leading industry figures as speakers. One session, entitled Partnering in the New Economy: The importance of leveraging unpartnered assets, is chaired by BioCentury’s Mike Ward and looks to help delegates maximize their Company’s IP value. Mike is assisted by some of Big Pharma’s key decision makers as panel speakers.
Another session, entitled Planning for Economic Resurgence, is chaired by William J. Kridel, Managing Director of Ferghana Partners Group. During the session a panel of experts from both the biotech and pharma industries will discuss how to plan for the expected resurgence of the capital markets and corporate transactional activity.
Sponsor Workshops - Leading Providers Offer Expert Insight on Unique Topics
BPE’s industry workshops have proven very popular as industry leaders are able to address unique and complex issues in great detail to interested delegates. One workshop, entitled Partnership Perils – and How to Avoid Them, is being headed by partnering experts Cooley Godward Kronish and will identify the current issues in partnering agreements and practical ways to maximize deal value whilst minimizing risk.
BioPartnering China Offers Key Insights into the Exciting Chinese Market
BPC is the second in a series of three conferences, building up to the launch of an annual BioPartnering conference in China that focuses on European companies and institutions seeking expansion into China, as well as Chinese companies seeking to enter the European market.
Highlights of this day include Keynote Speaker addresses from leading members of the Chinese biotech industry; Partnering Success Stories sessions, which will discuss companies’ experience in China; and face-to-face meetings, allowing delegates to meet a range of contacts from across the Chinese biotech and pharma industry.
View the online program for both BPE and BPC at: www.techvision.com/bpe/program.
Combined BPE and BPC Package – Attend both and receive a 20% discount!
BPC will immediately follow BPE and will be held at the QEII in London, on 14 October 2009. BPC will attract European companies and institutions seeking expansion into China, as well as Chinese companies seeking to enter the European market. The BPE & BPC Combo gives you a 20% discount off the full rate of both events and includes all benefits. For more details, visit: www.techvision.com/bpe
Face-to-face Partnering Powered by biopartnering.com
TVG’s unique meeting scheduler biopartnering.com is now live and delegates are already online and scheduling meetings. 90% of conference attendees rate biopartnering.com as the best conferencing software in the industry.
About Technology Vision Group
Since 1992, TVG has been connecting innovators and leaders in the life science industry across the US, Canada, China, Europe, Australia, Latin America, India, and Asia. TVG enables a global network that supports life science companies as they build new relationships, enter new markets, and create new products. Our 18-year track record (1992-2009) of success is founded on our deep industry knowledge, our integrity in business, and our powerful network of valuable relationships. TVG is judged by the company they keep and have helped over 3,200 life science companies achieve their business goals. TVG continues to expand their network into new markets in Latin America, China, and India — fulfilling their vision to be Your Global Life Science Network™.
About biopartnering.com
The TVG Partnering Network is built on our web-based platform, biopartnering.com, and our long-term relationships with industry leaders within leading companies and organizations across the US, Canada, China, Europe, Australia, Latin America, India, and Asia. TVG understand the value of strong partnerships across the industry and provide the network, tools, and the support to make those partnerships happen. Their conferences provide the venues where important face-to-face meetings happen supported by biopartnering.com, helping you develop the relationships you need to support the continued growth of your business.
Confirmed Presenting Companies (as of 18 September 2009):
Ablynx NV; Achaogen, Inc.; Addex Pharmaceuticals SA; Alchemia Pty. Ltd.; Allozyne; Ambit Biosciences; AM-Pharma B.V.; AngioChem Inc; aTyr Pharma Inc.; Auspex Pharmaceuticals; Avila Therapeutics, Inc.; Bioalliance Pharma S.A.; Biocompatibles Ltd.; Biolex Therapeutics; Biotecnol SA; Caprotec GmbH; Carolus Therapeutics, Inc.; CDG Therapeutics, Inc.; Celator Pharmaceuticals; Cerenis Therapeutics; Chaperone Technologies Inc.; Cornerstone Pharmaceuticals; Cytovance Biologics, Inc.; DBV Technologies; Debiopharm S.A.; Delcath Systems Inc; DesignMedix Inc; Emergent BioSolutions; Eureka Therapeutics, Inc.; Flamel Technologies S.A.; Heptares Therapeutics; ImmunoVaccine Technologies Inc.; iNovacia AB; Ironwood Pharmaceuticals; KAI Pharmaceuticals; KineMed, Inc.; Light Sciences Oncology, Inc; LineaGen, Inc.; Logical Therapeutics, Inc.; MicroBioChips ; Mithridion Inc; Molecular Partners AG; MorphoSys AG; Mpex Pharmaceuticals, Inc; Neogenix Oncology Corporation; Neurologix Inc.; Novacta Therapeutics; NovaMed Pharmaceuticals, Inc.; Novozymes A/S; Noxxon Pharma AG; Numerate, Inc.; Onco-D Therapeutics Inc.; Oncolytics Biotech Inc.; Otonomy, Inc; OxyPharma AB; Phylogica Limited; Pieris; Presidio Pharmaceuticals; ProteoTech Inc.; RaQualia Pharma, Inc.; Relypsa, Inc.; REVOTAR Biopharmaceuticals AG; Sangart; Savara Pharmaceuticals; Silence Therapeutics; SuperGen Inc.; Synosia Therapeutics; Syntaxin Ltd; Tetraphase Pharmaceuticals; Therosteon; Transcept Pharmaceuticals; UCB Group; Vakzine Projekt Management GmbH; ValiBIO; Vantia Ltd; VIVALIS; VLST Corp; Xention Limited; YM BioSciences Inc.; Zeta Biotech
Confirmed Exhibiting Companies (as of 18 September 2009):
BASi; BLIRT Sp. z i.e.; Health Protection Agency; LifeSciences British Columbia; Mawdsleys; Novozymes A/S; Pharmatek Laboratories Inc.; Piemonte Agency for Investment, Export and Tourism; Silence Therapeutics AG; Technology Vision Group LLC (TVG); UBIFrance; University of Nottingham; ValiBIO SA; Zoomedia
Conference Sponsors
Premium
AstraZeneca
Platinum
Deloitte
Gold
Cooley Godward Kronish LLP; Goodwin Procter LLP; Ferghana Partners Group; Taylor Wessing LLP
Silver
Amgen; Bristol-Myers Squibb Company; GlaxoSmithKline; Merck & Co.; Novartis; Perkins Coie; Pfizer Inc; PharmaLegacy; Piemonte Agency for Investment, Export and Tourism; F.Hoffmann - La Roche Ltd.; Takeda Pharmaceutical Company Limited
Conference Sponsor
Genzyme; ImmuPharma PLC; Johnson&Johnson FierceBiotech
Conference Supporter
Aura Capital Partners
Media Sponsors
Citigate Dewe Rogerson; Business Wire; Nature Publishing Group; Zoomedia; Pharmalicensing Ltd,
Media Supporters
BioBusiness; BioCentury; BioWorld Today; European BioPharmaceutical Review; GoingPublic Media AG; PharmaVentures Ltd.
Regional Affiliates Program Supporters
Asebio; ApBio; Assobiotec; Ausbiotech; BayBio; BayBio Institute; BayHelix Group; BIA; BioFlorida; BioMelbourne; Biominas; Bionow; BIOTECanada; EFB; ERBI; General Biologic; London Biotechnology Network; NIABA; Oxforshire Bioscience Network; SwedenBIO; SwissBiotech; UBI France; UK Trade & Investment
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
